Latest news
AbbVie (ABBV) Stock May Be 45% Below Fair Value As Rinvoq Expands In Europe - simplywall.stsimplywall.st · Sat, 08 Aug 2026 07:48:20 GMTWhat AbbVie’s Q2 Earnings Reveal About the Cost of the Apogee Deal - TIKR.comTIKR.com · Wed, 05 Aug 2026 18:40:09 GMTPrediction: AbbVie Will End The Year at This Price - 24/7 Wall St.24/7 Wall St. · Wed, 05 Aug 2026 14:00:26 GMTAbbVie (ABBV) Wins FDA Review For BOTOX Cosmetic In Jawline Treatment Push - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 22:11:42 GMTAbbVie (ABBV) Lifted Guidance, Has The Market Already Priced It In? - simplywall.stsimplywall.st · Tue, 04 Aug 2026 15:17:34 GMTThe Bull Case For AbbVie (ABBV) Could Change Following EU Approval Of Rinvoq For Vitiligo - webull.comwebull.com · Tue, 04 Aug 2026 08:36:41 GMTWhat Are Wall Street Analysts' Target Price for AbbVie Stock? - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 16:01:40 GMTAbbVie: Strong Q2 And New Catalysts Keep Me Bullish (NYSE:ABBV) - Seeking AlphaSeeking Alpha · Mon, 03 Aug 2026 14:05:31 GMT